KLF15在人肺腺癌中表達(dá)的臨床意義
[Abstract]:Objective Kr 眉 Kr 眉 ppel like factor 15 (Kr 眉 ppel-like factor 15 KLF15) is involved in the proliferation, invasion and metastasis of tumor, but the expression and role of Kr 眉 Kr 眉 KLF15 in lung adenocarcinoma is unclear. This study was to investigate the expression and clinical significance of KLF15 protein in patients with lung adenocarcinoma. Methods: the expression of KLF15 protein in 4 cases of lung adenocarcinoma and matched adjacent tissues were analyzed by Western blot. At the same time, the tumor tissue and clinical data of 72 patients with lung adenocarcinoma in our hospital were collected. The expression of KLF15 protein was analyzed by immunohistochemical staining, and the relationship between the expression of KLF15 protein and the clinical features, including prognosis, was analyzed. In addition, the expression of KLF15 in lung adenocarcinoma A549 cells was up-regulated by plasmid transfection. The effect of KLF15 protein on the proliferation of lung adenocarcinoma A549 cells was analyzed by CCK-8 method. Results: in 4 cases of lung adenocarcinoma and matched paracancerous tissues, the expression of KLF15 protein in lung adenocarcinoma was significantly lower than that in paracancerous tissues. In 72 cases of lung adenocarcinoma, there were 53 cases with low or no expression of KLF15 protein, 19 cases with high expression of KLF15 protein in 73.6 cases, and 19 cases with high expression of 26.4%.KLF15 protein. The 5-year survival rate was significantly better than that in patients with low expression of KLF15 (P0.01). The expression of KLF15 protein was significantly correlated with pathological stage (P0.01) and T stage (P0.01) of patients with lung adenocarcinoma, which was an important risk factor for poor prognosis of patients with lung adenocarcinoma. Upregulation of KLF15 protein in lung adenocarcinoma cells significantly inhibited the growth of lung adenocarcinoma cells. Conclusion KLF15 inhibits the growth of lung adenocarcinoma cells and may be a therapeutic target and prognostic molecular marker in lung adenocarcinoma patients.
【作者單位】: 暨南大學(xué)附屬第一醫(yī)院呼吸內(nèi)科;
【基金】:國家自然科學(xué)基金青年基金資助項(xiàng)目(No.81302030)
【分類號(hào)】:R734.2
【參考文獻(xiàn)】
相關(guān)期刊論文 前1條
1 黃志宏;駱文志;蔡興東;;KLF16在肺腺癌中表達(dá)的臨床意義及機(jī)制[J];中國病理生理雜志;2013年11期
【共引文獻(xiàn)】
相關(guān)期刊論文 前1條
1 劉曉妍;周利能;張蕾;蔡興東;;KLF15在人肺腺癌中表達(dá)的臨床意義[J];中國病理生理雜志;2017年08期
【二級(jí)參考文獻(xiàn)】
相關(guān)期刊論文 前1條
1 盧均坤;王艷芹;孫云暉;鮑文華;孫志廣;;非小細(xì)胞肺癌COX-2的表達(dá)與多藥耐藥性關(guān)系的研究[J];中國病理生理雜志;2008年03期
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 楊晉平,王澤,張?zhí)K;肺腺癌5-羥色胺受體的免疫組織化學(xué)定位[J];四川解剖學(xué)雜志;2003年02期
2 吳一龍,林嘉穎,楊學(xué)寧,喬貴賓,王坤,陳剛;肺腺癌患者酪氨酸激酶信號(hào)傳導(dǎo)通路的異常與臨床預(yù)后[J];中華醫(yī)學(xué)雜志;2004年12期
3 張利群,陳杭薇,王四海,辛慶紅,杜玉國,尤蘭華;人呼吸道合胞病毒轉(zhuǎn)錄調(diào)節(jié)基因轉(zhuǎn)染肺腺癌細(xì)胞系的研究[J];山東醫(yī)藥;2005年12期
4 黎聯(lián);梅同華;周向東;張新高;車德亞;;細(xì)胞外信號(hào)調(diào)節(jié)激酶信號(hào)通路與基質(zhì)金屬蛋白酶-26在肺腺癌表達(dá)中的關(guān)系[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2009年02期
5 王亞南;顧國浩;;生物芯片在肺腺癌研究和診療中的應(yīng)用進(jìn)展[J];國際檢驗(yàn)醫(yī)學(xué)雜志;2011年02期
6 ;我國人體肺腺癌細(xì)胞系建立[J];腫瘤;1981年06期
7 季晨陽,張義R,
本文編號(hào):2231072
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2231072.html